NEW YORK —Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a national securities and consumer rights litigation firm, is notifying investors that a class action lawsuit has been filed against Johnson & Johnson (NYSE: JNJ) (“J&J” or the “Company”) and other defendants, related to alleged violations of federal securities laws. If you purchased J&J securities between February 22, 2013, and February 7, 2018, you are encouraged to contact a Scott+Scott attorney at (844) 818-6982 for additional information.
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets.
According to the lawsuit, defendants made false or misleading statements and failed to disclose that J&J has known for decades that its talc products include asbestos fibers and that the exposure to those fibers can cause ovarian cancer and mesothelioma. J&J’s denials that talc could cause cancer and mesothelioma were materially false and misleading, and the Company concealed contingent liabilities and loss of future revenues from the product.
According to the complaint, following a September 21, 2017 Bloomberg article stating that documents indicate that J&J has known for decades that its talc products include asbestos fibers and that exposure to those fibers can cause ovarian cancer, and a February 5, 2018 CNBC report that court proceedings could expose potentially damaging documents, the value of J&J shares declined significantly.
What You Can Do
If you purchased J&J securities between February 22, 2013, and February 7, 2018, inclusive, or if you have questions about this notice or your legal rights, please contact attorney Joe Pettigrew at (844) 818-6982, or at [email protected].Investors have until April 9, 2018, to move for lead plaintiff.
About Scott+Scott, Attorneys at Law, LLP
Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.